Pembrolizumab-Induced Myocarditis Leading to Persistent Atrial Arrhythmias and a Cascade of Complications: A Therapeutic Dilemma.

Kichloo, Asim; Aljadah, Michael; Vipparla, Navya; Jamal, Shakeel; Kanjwal, Khalil

Kichloo, Asim; Aljadah, Michael; Vipparla, Navya; Jamal, Shakeel; Kanjwal, Khalil.

Kichloo A; Department of Internal Medicine,Samaritan Medical Center,Watertown, NY.
Aljadah M; Department of Internal Medicine,Medical College of Wisconsin,Milwaukee, WI.
Vipparla N; Department of Internal Medicine,Central Michigan University,Saginaw, MI.
Jamal S; Department of Internal Medicine,Central Michigan University,Saginaw, MI.
Kanjwal K; McLaren Greater Lansing Hospital, Michigan State University, Lansing, MI.

Am J Ther ; 28(5): e606-e608, 2020 Oct 28.

Article in English | MEDLINE | ID: covidwho-1494103

Subject(s)

Myocarditis; Antibodies, Monoclonal, Humanized/adverse effects; Arrhythmias, Cardiac; Humans; Myocarditis/chemically induced; Myocarditis/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Myocarditis Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google